Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for cbdMD (YCBD) over the last 10 years, with Q2 2025 value amounting to $5.8 million.

  • cbdMD's Shares Outstanding (Weighted Average) rose 118770.51% to $5.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.8 million, marking a year-over-year increase of 118770.51%. This contributed to the annual value of $54.9 million for FY2021, which is 2446.23% up from last year.
  • Per cbdMD's latest filing, its Shares Outstanding (Weighted Average) stood at $5.8 million for Q2 2025, which was up 118770.51% from $778410.0 recorded in Q1 2025.
  • Over the past 5 years, cbdMD's Shares Outstanding (Weighted Average) peaked at $59.3 million during Q2 2022, and registered a low of $370132.0 during Q1 2024.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $4.6 million (2024), whereas its average is $24.1 million.
  • As far as peak fluctuations go, cbdMD's Shares Outstanding (Weighted Average) tumbled by 9772.22% in 2023, and later skyrocketed by 118770.51% in 2025.
  • Quarter analysis of 5 years shows cbdMD's Shares Outstanding (Weighted Average) stood at $57.8 million in 2021, then crashed by 97.68% to $1.3 million in 2022, then surged by 120.76% to $3.0 million in 2023, then skyrocketed by 53.74% to $4.6 million in 2024, then grew by 27.05% to $5.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $5.8 million for Q2 2025, versus $778410.0 for Q1 2025 and $4.6 million for Q4 2024.